FDA Import Refusal AEK-1144132-4/11/1 — TORRENT PHARMACEUTICALS LTD
The FDA refused shipment AEK-1144132-4/11/1 from TORRENT PHARMACEUTICALS LTD (India) on May 20, 2022. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 20, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75